Next generational MIGS
Location: United States, New York, White Plains
Employees: 11-50
Total raised: $95M
Founded date: 2019
Investors 4
| Date | Name | Website |
| 10.07.2026 | US Venture... | usvp.com |
| 15.09.2025 | aMoon Fund | amoon.fund... |
| 26.09.2022 | Visionary ... | visionaryv... |
| - | Civilizati... | civilizati... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 29.04.2026 | - | $30M | - |
| 20.08.2025 | Series C | $42M | - |
| 29.08.2022 | Series B | $23M | - |
Mentions in press and media 7
| Date | Title | Description |
| 29.04.2026 | Iantrek Receives $30M in Growth Capital From Trinity Capital | Iantrek, a NYC-based medical technology company which specializes in the bio-interventional ophthalmic surgery (BIOS), received $30M in growth capital from Trinity Capital Inc. (Nasdaq: TRIN). This debt facility followed a Series C raise in... |
| 29.04.2026 | Iantrek Secures $30 Million In Growth Capital From Trinity Capital To Expand Ophthalmic Surgery Platform | - |
| 20.08.2025 | Iantrek Raises $42 Million Series C | WHITE PLAINS, NY, Iantrek, a pioneer in bio-interventional ophthalmic surgery (BIOS), announced the close of a $42 million Series C financing round. >> Click here for more funding data on Iantrek >> To export Iantrek funding da... |
| 20.08.2025 | Iantrek Raises $42 Million Series C to Launch AlloFlo™ Uveo, a Breakthrough Interventional Glaucoma Therapy | - |
| 20.08.2025 | Iantrek sees $42M fundraising for alternative glaucoma surgery launch | The developer of an alternative surgical approach to glaucoma has raised $42 million to bolster the commercial launch of its hardware-free, tissue-based solution for relieving intraocular pressure. Iantrek’s AlloFlo Uveo system is designed ... |
| - | Iantrek | “Iantrek is dedicated to meaningful innovation and developing next-generation technologies for total-outflow enhancement. Learn more today.” |
| - | Iantrek | “Iantrek | Home” |